Annual report pursuant to Section 13 and 15(d)

Business (Details Narrative)

v2.4.0.8
Business (Details Narrative)
12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2011
BioZone [Member]
Jun. 30, 2011
BioZone [Member]
Dec. 31, 2011
Equalan [Member]
Jun. 30, 2011
Equalan [Member]
Dec. 31, 2011
Equachem [Member]
Jun. 30, 2011
Equachem [Member]
Dec. 31, 2011
BetaZone [Member]
Jun. 11, 2011
BetaZone [Member]
Acquisition of outstanding common stock of BioZone Labs     100.00%   100.00%   100.00%   45.00%
Exchanged outstanding stock into shares of common stock 21,000,000 19,266,055   1,027,523   385,321   321,101